How Does X-Ray Crystallography Aid in Drug Development?
By revealing the detailed structure of cancer-related proteins and their binding sites, X-ray crystallography enables the rational design of targeted therapies. For example, the structure of the BCR-ABL fusion protein, responsible for chronic myeloid leukemia, was elucidated using this technique, leading to the development of the drug Imatinib.
